Terry Gregg, CEO, Dexcom, answers Steve’s questions about using CGM technology to help type 2 diabetes patients learn about blood sugar control. He reveals that he frequently talks about the greater role in behavior modification that CGM could play in helping not only those diagnosed with diabetes but perhaps even …

Terry Gregg, CEO, Dexcom, discusses the current landscape of reimbursement for CGM technology. Although insurance companies were initially slow to catch on for approving CGM devices for type 1’s, there has been a shift and approvals seem to be improving. He is also sees the overall market increasing as more …

Terry Gregg, CEO, Dexcom, shares his thoughts on a “cure” for diabetes, commenting that 20 years ago, he was told it would happen in 5-7 years. At this time he believes it is still a way off and that, “Realistically, we’ll proobably find a way to prevent it before we …

Last week I started two patients on V-GO devices. For those of you who are not familiar with the device it is a simple mechanical (not electrical) device that can deliver a basal of 20, 30, or 40 units of insulin a day and allow your patients to deliver up …

Sometimes the simplest things can be the hardest to do correctly, and nowhere else could it be more devastating than when a glucagon kit is not used properly. In this week’s Disaster Averted, see what could happen when a medical professional gets ahold of a simple-to-use device and overthinks it. …

Terry Gregg, CEO, Dexcom, talks about the increases in CGM accuracy which Dexcom is working towards, as well as the cooperative efforts they are involved in with working towards an effective artificial pancreas. He says that one of the goals of Dexcom is to “eliminate fingersticks” and they are getting …

  In this week’s series of Homerun Slides, we take a more detailed look at the most recently approved SGLT2 inhibitor, dapagliflozin, and then explore some of the other SGLT2 inhibitors which are on the horizon….

Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP   Islet structure and function Insulin is synthesized in and secreted from the β-cells within the islets of Langerhans in the pancreas. The normal pancreas has about 1 million islets, which constitute about 2-3% of the gland’s mass. All of the islet …

Researchers found that desserts made with added soluble fiber (dextrin) and sucralose in place of added sugar, had positive effects on blood sugar and insulin levels in people with type 2 diabetes. Consumption of desserts made with sucralose and soluble fiber did not raise after-meal levels of glucose, insulin or …

A survey of parents whose children were enrolled at an obesity clinic found that 31.4% believed their child’s health was excellent or very good, and 28% did not see being overweight as a health problem. Parents were more likely to support dietary changes for their child over getting an hour …